Eckhardt Sue Gail 4

What Happened

• Director Eckhardt Sue Gail sold 9,812 shares of Exelixis, Inc. (EXEL) on June 1, 2026. The sales were open-market transactions with a weighted-average price of $50.14, generating total proceeds of $491,974. Prices on individual trades ranged from $49.73 to $50.61.

Key Details

• Transaction date: 2026-06-01; Sale (S) — open market/private sale.
• Price details: weighted average $50.14; per-trade range $49.73–$50.61.
• Proceeds: $491,974 (total).
• 10b5-1 plan: Sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2025 (see footnote).
• Shares owned after transaction: the filing does not state a post-sale total; it notes the reporting person has 16,079 restricted stock units (RSUs) that will convert to common shares upon vesting.
• Filing timeliness: Form 4 was filed on 2026-06-03 for a 2026-06-01 transaction — filed within the standard two-business-day window (timely).

Context

• The sale was executed under a prearranged 10b5-1 plan, which typically schedules trades in advance and is considered routine; this does not necessarily indicate a change in the director’s view of the company. The filing notes unvested RSUs (16,079) that will become shares upon vesting.